Janelidze, S., Collij, L. E., Mattsson-Carlgren, N., Antill, A., Laymon, C. M., Lott, I., Rosas, H. D., Minhas, D. S., Luo, W., Zaman, S., Mapstone, M., Head, E., Lai, F., Hartley, S. L., Ances, B. M., Krinsky-McHale, S. J., Lee, J. H., Ossenkoppele, R., Christian, B. T., … Hansson, O. (2025). Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study. The Lancet Neurology, 24(7), 591–600. https://doi.org/10.1016/s1474-4422(25)00158-9
Subjects:
Down Syndrome
(MeSH)
tau Proteins
(MeSH)
Amyloid beta-Peptides
(MeSH)
Cognitive Dysfunction
(MeSH)
Brain
(MeSH)
Publication Type:
Article
Unique ID:
10.1016/s1474-4422(25)00158-9
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Source Link: